ai3Bio launches from stealth, Matchpoint's big raise for new autoimmune drug, layoffs at Foghorn and Enanta
Plus another Eli Lilly acquisition moves to Arsenal Yards
C4's Partnership with Roche, Gilead Options Kymera degrader, and Astellas Licenses Dyno Capsid
Plus the initial dosing of Enanta and Avencell's Clinical Trials
Labshares Expanding to Watertown
Neumora's Wegovy alternative, Dyno announces manufacturing pact, and more